menu search

ELTP / Elite Pharmaceuticals, Inc.'s (ELTP) CEO Nasrat Hakim on Q4 2022 Results - Earnings Call Transcript

Elite Pharmaceuticals, Inc.'s (ELTP) CEO Nasrat Hakim on Q4 2022 Results - Earnings Call Transcript
Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q4 2022 Earnings Conference Call June 30, 2022 11:30 AM ET Company Participants Nasrat Hakim - President and CEO Robert Chen - Chief Financial Officer Dianne Will - Vice President, Investor Relations Conference Call Participants Operator Good morning, ladies and gentlemen. And welcome to the Elite Pharmaceuticals Conference Call. Read More
Posted: Jun 30 2022, 17:39
Author Name: Seeking Alpha
Views: 110168

ELTP News  

Q4 Stock Predictions: 7 Penny Stocks Ready to Roar Into 2024

By InvestorPlace
October 9, 2023

Q4 Stock Predictions: 7 Penny Stocks Ready to Roar Into 2024

When it comes to stock predictions and penny stocks to buy, admittedly the near-term picture remains cloudy. Right now, it's unclear whether high inte more_horizontal

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2024 Financial Results on August 15, 2023

By Accesswire
August 9, 2023

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2024 Financial Results on August 15, 2023

Financials for First Quarter Fiscal Year 2024 Ended June 30, 2023 will be released on August 14, 2023 NORTHVALE, NJ / ACCESSWIRE / August 9, 2023 / El more_horizontal

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2023 and Provides Conference Call Information

By Accesswire
June 29, 2023

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2023 and Provides Conference Call Information

Conference Call Scheduled for Friday, June 30 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 29, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the more_horizontal

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2023 Financial Results on June 30, 2023

By Accesswire
June 22, 2023

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2023 Financial Results on June 30, 2023

Financials for Fiscal Year 2023 Ended March 31, 2023 will be released on June 29, 2023 NORTHVALE, NJ / ACCESSWIRE / June 22, 2023 / Elite Pharmaceutic more_horizontal

Elite Pharmaceuticals, Inc. (ELTP) Q3 2023 Earnings Call Transcript

By Seeking Alpha
February 15, 2023

Elite Pharmaceuticals, Inc. (ELTP) Q3 2023 Earnings Call Transcript

Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q3 2023 Earnings Conference Call February 15, 2023 11:30 AM ET Company Participants Nasrat Hakim - President more_horizontal

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023 ended December 31, 2022 and Provides Conference Call Information

By Accesswire
February 14, 2023

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023 ended December 31, 2022 and Provides Conference Call Information

Conference Call Scheduled for Wednesday, February 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 14, 2023 / Elite Pharmaceuticals, Inc. ("El more_horizontal

Elite Pharmaceuticals, Inc.'s (ELTP) CEO Nasrat Hakim on Q4 2022 Results - Earnings Call Transcript

By Seeking Alpha
June 30, 2022

Elite Pharmaceuticals, Inc.'s (ELTP) CEO Nasrat Hakim on Q4 2022 Results - Earnings Call Transcript

Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q4 2022 Earnings Conference Call June 30, 2022 11:30 AM ET Company Participants Nasrat Hakim - President and more_horizontal

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2022 and Provides Conference Call Information

By Accesswire
June 29, 2022

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2022 and Provides Conference Call Information

Conference Call Scheduled for Thursday, June 30 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 29, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or t more_horizontal


Search within

Pages Search Results: